Navigation Links
Study Makes Strides in Understanding Ovarian Cancer
Date:4/26/2010

Findings may lead to development of screening tests for early detection

MONDAY, April 26 (HealthDay News) -- New understanding about the early stages of ovarian cancer may lead to the development of a new screening test for the cancer, U.S. researchers say.

In the study, scientists uncovered early tumors and precancerous lesions in inclusion cysts, which fold into the ovary from its surface.

"This is the first study giving very strong evidence that a substantial number of ovarian cancers arise in inclusion cysts and that there is indeed a precursor lesion that you can see, put your hands on, and give a name to," lead author Jeff Boyd, chief scientific officer at Fox Chase Cancer Center in Philadelphia, said in a news release. "Ovarian cancer most of the time seems to arise in simple inclusion cysts of the ovary, as opposed to the surface epithelium."

Boyd and his colleagues analyzed ovaries removed from women with BRCA gene mutations (who have a 40 percent lifetime risk of developing ovarian cancer) and from women with no known genetic risk factors for ovarian cancer.

In both groups of women, gene expression patterns in the cells of inclusion cysts were dramatically different than normal ovarian surface cells. For example, the cells of inclusion cysts had increased expression of genes that control cell division and chromosome movement. The researchers also found that cells from very early tumors and tumor precursor lesions frequently had extra chromosomes.

"Previous studies only looked at this at the morphologic level, looking at a piece of tissue under a microscope," Boyd said. "We did that but we also dissected away cells from normal ovaries and early-stage cancers, and did genetic analyses. We showed that you could follow progression from normal cells to the precursor lesion, which we call dysplasia, to the actual cancer, and see them adjacent to one another within an inclusion cyst."

With these findings, researchers can try to develop new screening tests to detect ovarian cancer in the earliest stages, when it is still treatable. Ovarian cancer kills nearly 15,000 women in the United States each year. Fewer than half of ovarian cancer patients live more than five years after diagnosis.

The study was published April 26 in the journal PLoS One.

More information

The American Cancer Society has more about ovarian cancer.



-- Robert Preidt



SOURCE: Fox Chase Cancer Center, news release, April 26, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Brown Rice Tied to Better Heart Health in Study
2. NIH study confirms location of stem cells near cartilage-rich regions in bones
3. Immune cells predict success of head and neck cancer treatment, U-M study finds
4. Noncardiac Chest Pain May Warrant More Management: Study
5. SGIC Study Finds Drivers Are Losing Their Cool At School
6. Health impacts of mobile phone use to be explored in huge new study
7. Study of Williams syndrome patients reveals specific genes role in intelligence
8. Study Finds Patients Breathe Easier After Weight-Loss Surgery
9. Knowledge is power in Penn State blood pressure study
10. Breast density change linked to cancer development in WHI hormone replacement study
11. Ovarian cancer study offers vital clues for new therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive Laboratories™ is one ... glutathione to enhance production of nitric oxide (NO). , NitroGenesis Pro™ is made ... NO twice as effectively and sustains NO blood levels twice as long as ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders are equal ... Castlewood Treatment Centers has always been to promote the power of recovery, and ... possible. In that spirit, Castlewood has announced two new hires, both Outreach Directors ...
(Date:12/5/2016)... ... December 05, 2016 , ... U.S. Apple Association (USApple) begins the ... the second annual Apples for Education: Buy an Apple, Help a Student ... food for students to take home to their families; solar technology to efficiently process ...
(Date:12/5/2016)... GREENWICH, CT and MALVERN, PA (PRWEB) , ... ... ... Clinical Supplies Management ("CSM"), a Great Point Partners ("GPP") portfolio company, ... Clinical Research – Clinical Supplies ("TCS"). TCS was previously a subsidiary ...
(Date:12/5/2016)... ... 05, 2016 , ... The legislation – S2718A/A2116A ... a licensed physical therapist, to render care for certain patients. In most cases, ... a licensed physical therapist (PT) and throughout the treatment cycle is supported by ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... SANTA MONICA, Calif. , Dec. 5, 2016 /PRNewswire/ ... PINK: PRLX), is pleased to announce that its pharmaceutical ... serve Medicare B clients, allowing coverage in all of ... business in. Michael Rashti Pharm ... "This is a very exciting for our business. Medicare ...
(Date:12/5/2016)... Dec. 5, 2016  Pennsylvania Physician General Dr. ... Programs Gary Tennis today filled prescriptions for ... Pharmacy in York to demonstrate ... Dr. Levine as a prescription to acquire naloxone at ... important to remember that any Pennsylvanian can walk up ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. ... the Commercialization of Public Research (the Florida ... funding agreement SegAna, LLC, an Orlando ... of Central Florida. The Florida Institute supports new ... early funding gaps for companies spinning out of Florida-based ...
Breaking Medicine Technology: